Evidence map›Paper›PMID 33628606›Full record

ReviewMycology2020

Dual identities for various alcohols in two different yeasts.

Nitin Mahendra Chauhan, S Mohan Karuppayil

Open access · goldAbstract readReview
In one paragraph

Review in Mycology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. First Evidence of Metabolically Active Intracellular Bacteria inJournal of agricultural and food chemistry · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. EnhancingMicroorganisms · 2022
    Article
  7. From Jekyll to Hyde: The Yeast-Hyphal Transition ofPathogens (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Nitin Mahendra ChauhanCollege of Natural and Computational Sciences, Dilla University, Dilla, Ethiopia.ORCID https://orcid.org/0000-0003-3055-0540
S Mohan KaruppayilProfessor and Head, Department of Stem Cell & Regenerative Medicine and Medical Biotechnology, D Y Patil Education Society, Kasaba Bawada, Kolhapur, Maharashtra 416006, India.ORCID https://orcid.org/0000-0002-5583-0381
Dilla University · ETD.Y. Patil Education Society · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most of the yeast bypasses the developmental stage from simple unicellular yeast to elongated structure like hyphae. Regulation of this transition is governed by various quorum sensing and signalling molecules produced under different conditions of growth, that differ significantly, both physiologically and chemically. The evidence of fungal quorum sensing was uncovered ten years ago after the discovery of farnesol as first eukaryotic quorum sensing molecules in Candida albicans. In addition to farnesol, tyrosol was identified as second quorum sensing molecules in C. albicans controlling physiological activities. After the discovery of farnesol and tyrosol, regulation of morphogenesis through the production of chemical signalling molecules such as isoamyl alcohol, 2-phenylethyl alcohol, 1-dodecanol, E-nerolidol, etc. is reported in C. albicans. Some of the evidence suggests that the budding yeast Saccharomyces cerevisiae exhibits this type of regulation and the signals are regulated by aromatic alcohols which are the end product of amino acid metabolism. The effects of these molecules on morphogenesis are not similar in both yeasts, making comparisons hard. It is hypothesized that these signals works in microorganisms to derive a competitive advantage. Here, we present an example for utilization of competitive strategy by C. albicans and S. cerevisiae over other microorganisms.

Indexed as

alcohol dehydrogenasebiofilmsCandida albicansfusel alcoholsQuorum sensingsaccharomyces cerevisiae

Identifiers

PMID33628606
PMCPMC7889121
OpenAlexW3113226538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.